Ali McBride, PharmD, MS, BCOP, is the Clinical Coordinator of Hematology/Oncology at The University of Arizona Cancer Center. He currently serves as President-Elect of the Association of Community Cancer Centers (ACCC). In addition to being a long-time ACCC member, Dr. McBride has been actively involved with the American Society of Health-System Pharmacists (ASHP) and the Hematology/Oncology Pharmacy Association (HOPA).
Dr. McBride has been working on oncology drug shortages and has testified on behalf of HOPA at the U.S. Food and Drug Administration (FDA) Drug Shortage Workshop; presented on behalf of ACCC at the Washington, D.C., Congressional Session; and was an invited member of the ASHP Drug Shortage Stakeholders Meeting. Dr. McBride is also actively involved with biosimilar regulation and the pharmacoeconomic impact of biosimilars into the U.S. marketplace. He currently serves as a working group member for HOPA on its biosimilar committee. In addition, he serves on the National Quality Forum Cancer Standing Committee. He has published numerous articles on drug shortages, oral chemotherapy adherence, stem cell transplant, and biosimilar implementation into the U.S. healthcare market.
Randall A. Oyer, MD, is a practicing medical oncologist at the Ann B. Barshinger Cancer Institute at Penn Medicine Lancaster General in Lancaster, Pennsylvania. He serves as the Medical Director of the Cancer Institute, Medical Director of Oncology, Chairman of Cancer Committee, Chair of the Oncology Physicians Advisory Council, and Medical Director of the Cancer Risk Evaluation (Cancer Genetics) Program at Penn Medicine Lancaster General. Dr. Oyer is a member of the Cancer Service Line Executive Committee and the Cancer Service Line Quality Committee at the Abramson Cancer Center─University of Pennsylvania, Philadelphia.
Dr. Oyer divides his time among patient care, program administration, program development, and community outreach. He works closely with a multidisciplinary team that comprises nursing, social work, pharmacy, chaplaincy, and medical specialties focused on strategy, implementation, and patient care.
A long-standing active member of the Association of Community Cancer Centers (ACCC), Dr. Oyer is currently serving on the Board of Trustees as member and Treasurer. He is also an ex-officio Commissioner of the American College of Surgeons Commission on Cancer, representing the ACCC.
Dr. Oyer is serving co-chair of the Advisory Committee for the ACCC Optimal Care Coordination Model for Lung Cancer Patients on Medicaid education project. He is an active member of the ACCC Governmental Affairs Committee, participating in Capitol Hill visits and advocating on behalf of community cancer care. Previously, Dr. Oyer served as an Advisory Committee member for the ACCC Molecular Testing education project, and he has presented a several ACCC meetings.
In addition to his participation in ACCC, he has served as a member of the Centers for Medicare & Medicaid Services (CMS) Ambulatory Payment Classification Panel and of the American Society of Clinical Oncology (ASCO) Clinical Practice Committee.
Dr. Oyer is a graduate of Georgetown University and Georgetown University School of Medicine.
David R. Penberthy, MD, MBA, is Immediate Past President of Virginia Radiation Oncology Associates, Inc., a private medical practice based in Richmond, Virginia, where he has practiced since completing residency at the University of Virginia in 2002. After completing his MBA from the Darden School of Business at the University of Virginia in 2011, Dr. Penberthy has served as the Medical Director of Radiation Oncology and Cancer Committee Chairman at Southside Regional Medical Center (SRMC) in Petersburg, Virginia. During his tenure as chairman, Dr. Penberthy led SRMC’s oncology program through two American College of Surgeons Commission on Cancer accreditation surveys resulting in cancer program accreditation, each time earning an Outstanding Achievement Award, an accolade achieved by only a small fraction of community oncology programs in the country.
After earning a Bachelor of Science degree in Electrical Engineering from Virginia Tech and a Doctor of Medicine degree from Virginia Commonwealth University, Dr. Penberthy completed a surgical internship at Bethesda Naval Hospital. He then served as a U.S. Navy Flight Surgeon with Fighter Squadron 101 in Oceana, Virginia. His strong interest and knowledge of technology eventually led him to the field of Radiation Oncology. In this field, Dr. Penberthy applies sophisticated medical technologies to alleviate the suffering caused by cancer, one of the most pressing medical issues of our generation.
Dr. Penberthy is enthusiastic about patient care and he is intensely engaged in providing state of the art, patient centered, compassionate oncology care.
Krista Nelson, MSW, LCSW, OSW-C, BCD, is trained as an oncology social worker and works in clinical, research, and program management roles within Providence Health and Services. Ms. Nelson recently joined the Compassion team as a Program Manager, and she appreciates the opportunity to bring her clinical expertise to work on creating supportive infusions of compassion to caregivers.
She provides individual support as well as group support for those affected with cancer. She facilitates a Young Survival Coalition (YSC) online support group for women with metastatic cancer and runs a program for children with a parent with cancer. In 2015 Providence Cancer Center received an ACCC Innovator Award for its Family Program for Parents with Cancer and Their Children.
Ms. Nelson defines her role as providing support for people and their families throughout the cancer continuum and sharing the expertise that she has learned from other patients with cancer. In working with those affected by cancer, she loves, “being able to witness the grace, courage, and life lessons of individuals dealing with cancer and the opportunity to be a part of their journey.”
She is a Past President of the Board of Directors of the Association of Oncology Social Work (AOSW) and past Invited Director of the American Psychosocial Oncology Society (APOS). She loves being a part of the national discussion involving the psychosocial care of people with cancer.
She has been a speaker at local and national conferences on issues of survivorship, palliative care, distress screening, and children who have a parent with cancer. Krista also serves as an Invited Director on the board of directors of the National Accreditation Program for Breast Centers (NAPBC), and as a Director of the American Clinical Social Work Association (ACSWA). In 2015, Krista was named as a finalist in the Schwartz Center Compassionate Caregiver of the Year Award.
Krista also has been a volunteer facilitator at retreats for women with breast cancer and at camps and programs that support grieving children. She also has volunteered annually on medical relief teams to Haiti since 2009.
Thomas A. Gallo, MS, MDA, is executive director of the Virginia Cancer Institute in Richmond, Virginia. In this role, he manages all aspects of a 24-provider medical oncology practice with 7 medical offices, ambulatory infusion centers, laboratories, and more than 200 employees. Among his responsibilities are strategic planning, operations, financial management, personnel management, and purchasing.
Mr. Gallo has been an active member of the Association of Community Cancer Centers (ACCC) for more than 10 years. He served as ACCC President-Elect 2017-2018. Currently, he also serves on ACCC’s Governmental Affairs Committee, which he previously chaired. He has presented at a number of ACCC Annual Meetings and has previously served on the ACCC Board of Trustees (2004-2005).
In addition to his involvement with ACCC, Mr. Gallo is a member of the Board of Directors of MD Value Care, an ACO of independent physician practices; past president of the Executive Committee of the MGMA Administrators in Oncology-Hematology Assembly (AOHA); a current member and former president of the Board of Directors of the Virginia Association of Hematologists and Oncologists (VAHO); and a former board member of the Community Oncology Alliance.
Prior to entering the healthcare field, Mr. Gallo was a commercial banker with Marine Midland Bank in New York City and Central Fidelity Bank in Richmond, Virginia.
He received a BA in Economics from the College of William and Mary in Williamsburg, Virginia, and an MS in Finance and a Master of Decision Analytics (MDA) degree from Virginia Commonwealth University, where he was a Dean’s Scholar.
Olalekan “Lekan” Ajayi, PharmD, MBA, is oncology service line manager at Sheridan Memorial Hospital in Sheridan, Wyoming. In this role, Dr. Ajayi oversees both strategic and operational initiatives of the oncology and internal medicine programs. He has also worked extensively as a clinical pharmacist and an oncology pharmacy manager for eight years.
Dr. Ajayi currently serves on the ACCC Board of Trustees and has worked on a number of ACCC initiatives.
He is passionate about patient access to quality cancer care in rural communities. Specifically, Dr. Ajayi is interested in expanding patient access to oncology clinical trials and is working with ACCC on ways to overcome the challenges of patient accruals for clinical trials in rural cancer programs.
He holds a Doctor of Pharmacy degree from the University of Wyoming, and a Master’s in Business Administration from the University of Colorado, Denver.
Dr. Nadine J. Barrett is a medical sociologist and an assistant professor in the Department of Community and Family Medicine, within Duke University’s School of Medicine. She is the inaugural director of the Office of Health Equity and Disparities at the Duke Cancer Institute and serves as the director of the Duke Community Engagement Core, within the Center for Community and Population Health Improvement. A health equity and stakeholder engagement strategist, Dr. Barrett applies her expertise across three interrelated areas: 1) linking vulnerable communities to health services and research, 2) leveraging community and health system assets and services to align priorities and improve community and population health, and 3) convening diverse stakeholders to develop community and patient-centered programs, services, and research.
In 2017, she accepted an ACCC Innovator Award on behalf of Duke Cancer Institute for its initiative, Come Together: A Health Disparities & Equity Cancer Program Built on Community Collaboration. She is the recipient of several awards, including the American Sociology Association’s Minority Fellowship Award, an NIH Postdoctoral Fellowship in Health Services Research, and the MLK Southern Christian Leadership Conference Drum Major for Justice Award. Her national appointments include the PCORI Health Disparities Advisory Panel Board and the ACCC Board of Trustees. Dr. Barrett is both passionate about and committed to achieving health equity.
Dr. Barrett has several funded projects including Project PLACE (Population Level Approaches to Cancer Elimination), funded by the National Cancer Institute (NCI), which is a three-pronged research project designed to implement three robust mechanisms to inform the health equity strategic direction of the Duke Cancer Institute over the next five to eight years. Project PLACE is a highly intensive community engagement model and platform designed to shape robust scholarly productivity, partnered research and community programs to improve population health. She is also the Duke PI (subcontract) of a national Susan G. Komen pipeline training grant on translational research in inflammatory breast cancer and community-engaged research. Dr. Barrett also co-directs the NCI-funded Cancer Research and Education Program Core of the NCCU/DCI Translational Health Disparities Research Program which incorporates specified training in minority accrual in clinical research—a program she developed within the Duke Cancer Institute titled, “Just Ask.”
Nina K. Chavez, MBA, FACMPE, is the chief operating officer of New Mexico Oncology Hematology Consultants, Ltd. (NMOHC) that operates the New Mexico Cancer Center (NMCC) at its flagship Albuquerque practice location and at its center in Gallup, New Mexico. Over the past 14 years, Ms. Chavez has grown with NMOHC as it too has grown from her hiring in 2004 as human resources manager through to her current position as chief operating officer – second in command to Dr. Barbara L. McAneny, CEO and Founder. Ms. Chavez oversees and facilitates the daily operations of both NMCC centers and works to ensure that the 180 total physicians and staff members provide the most compassionate and comprehensive patient-centered cancer care available throughout New Mexico. Through her leadership, NMOHC has earned the distinction of being the first in the nation NCQA-certified Level 3 Oncology Medical Home, and the only one in the state of New Mexico.
Amanda A. Henson, MSHA, MBA, FACHE, is Vice President of Oncology at Baptist Health Lexington, a community-based hospital located in Lexington, Kentucky. Baptist Health Lexington is part of Baptist Health; a health system comprised of nine hospitals throughout Kentucky and Southern Indiana, and headquartered in Louisville, Kentucky. As Vice President, Ms. Henson is responsible for the administrative oversight, financial management, and overall program development for the cancer service line. In addition, Ms. Henson has administrative responsibilities for several other departments at Baptist Health Lexington, including the hospital foundation office, environmental services, laundry, materials management, clinical research and community education.
Ms. Henson leads system-wide initiatives including Executive Sponsor of the Cancer Service Line Council and Co-Sponsor of the Research Resource Council for Baptist Health System. Ms. Henson helped lead the integration of federally funded oncology research collaboration for all Baptist hospitals under the Baptist Health Cancer Research Network. In addition, Ms. Henson has been involved in the development of Baptist Health’s first system service line council. This council is instrumental in standardization of oncology care, dashboard quality metrics, and strategic planning.
Throughout her career in oncology management, both in an academic medical center and community cancer centers, Ms. Henson has successfully led programs through accreditation surveys with the Commission on Cancer (CoC), as well as the National Accreditation Program for Breast Centers (NAPBC). She has extensive experience implementing oncology EMR systems. Additionally, during her previous role as Administrative Director of Cancer Services at DCH Regional Medical Center in Tuscaloosa, Alabama, Ms. Henson was responsible for overseeing the construction of a 90,000-square-foot cancer center.
Ms. Henson previously served on the Association of Community Cancer Centers (ACCC) Editorial Committee and Nominating Committee. She is Past President of the University of Alabama at Birmingham’s Graduate Program in Healthcare Administration Alumni Board. Currently she serves as a preceptor for healthcare management students from the University of Kentucky and is actively engaged in community programs and civic organizations, including serving on the board for Court Appointed Special Advocates (CASA) of Lexington.
Ms. Henson received her undergraduate degree from Centre College, in Danville, Kentucky. She also received her MBA and MSHA degrees from the University of Alabama at Birmingham. Ms. Henson is a Fellow within the American College of Healthcare Executives and is the 2015 recipient of the Early Career Healthcare Executive Regent’s Award from the Kentucky Chapter of American College of Healthcare Executives (ACHE).
Una Hopkins, RN, FNP-BC, DNP, is a registered nurse with more than 30 years of experience in oncology, 25 as a nurse practitioner. Dr. Hopkins is currently the director for research and evidence-based practice at the Montefiore Medical Center in Bronx, New York, where she is responsible for the oversight and management of nurse engagement in programs of research and evidence-based practice, academic and affiliations, nursing internet and intranet development, and presentations and publications for the department of nursing. This includes the management of selected staff and operations, academic affiliations and funded educational projects, survey preparation, specialized training initiatives, education related to promotion of nursing research and evidence-based practice, oversight of project management, and funding attainment.
Dr. Hopkins has received numerous awards for her accomplishments in clinical and research work and since 1927, has published over 20 articles in various medical journals. She holds bachelor’s and master’s degrees in Nursing Science from the College of New Rochelle where she also studied to become a family nurse practitioner. She received her doctorate from Pace University in New York City. Dr. Hopkins serves on the Advisory Committee for the ACCC Institute for Clinical Immuno-Oncology.
As CEO of Highlands of Oncology Group in northwest Arkansas, Jeff Hunnicutt has demonstrated a unique skill set and a passion for his work. Specializing in comparative analytics in oncology, Mr. Hunnicutt has helped drive the success of his practice by providing an in-depth look into the underlying data that now gives direction to operational decisions. He has been recognized for his efforts by participating on the CMMI Oncology Care Model (OCM) Redesign team with the Community Oncology Alliance (COA), the Value Based Care Reform group with Catholic Health Initiatives (CHI), and in his role as executive director of the Quality Cancer Care Alliance (QCCA).
Mr. Hunnicutt and his family are deeply involved in projects to bring quality education to the remote areas of Senegal, Africa, and to raising awareness for the foster system in their state.
Barbara Jensen, RN, BSN, MBA, is a dynamic nurse leader and the Director of Oncology, Diagnostic Imaging and Palliative Care at Skagit Regional Health in Mount Vernon, Washington. Ms. Jensen has over 22 years of healthcare experience in a variety of settings to include oncology, home health, home infusion, orthopedic and surgical care, and wound care. As an ad hoc teaching faculty member for the Skagit Valley Community College Nursing Program, Ms. Jensen teaches “Oncology 101” as an introduction to oncology for second year students, laying the foundation for oncology patient nursing management. A long-time ACCC member, Ms. Jensen currently serves on the ACCC Guidelines Committee.
During her tenure as Director of Oncology she has led her team through successful accreditation surveys for the cancer center to include the Commission on Cancer (CoC) with Commendation, National Accreditation Program for Breast Centers (NAPBC), and the Quality Oncology Practice Initiative (QOPI) certification program. Since 2010 she has worked with the multidisciplinary team of The Breast Institute to improve breast cancer screening volumes and technology in the Skagit Valley, and will see this come to fruition in a new women’s imaging center set to open early 2019 that will bring 3-D mammography to the region.
With a heart for philanthropy, Ms. Jensen is a past member of the Hospice of the Northwest Board of Trustees helping to raising both awareness and funds for the local hospice program. Currently she is serving on the Board of Directors of the Skagit Valley Hospital Foundation supporting their mission to raise funds that will ensure the continued availability of quality health care services for the patients in Skagit Valley.
Ms. Jensen obtained her BSN degree at Seattle Pacific University and an MBA with a focus on healthcare from Western Governors University.
Dr. Shiller is board certified in Anatomic, Clinical, and Molecular Genetic Pathology following completion of residency at Baylor University Medical Center in Dallas, Texas, and fellowship at The Mayo Clinic in Rochester, Minnesota. Upon completion of training, Dr. Shiller established practice with Pathologists Biomedical Laboratories in Dallas, Texas, which services the majority of the Dallas-Fort Worth metroplex Baylor Scott and White Hospitals. As a result of her experience, she has served on multiple committees considering testing implementation and utilization. Dr. Shiller serves on the Quality Committee for the Baylor Sammons Cancer Center, and as assistant medical director for Cancer Genetics, primarily focusing on germline cancer predisposition, as well as Co-Assistant Medical Director for the Division of Molecular Medicine and Pathology. Finally, within the Baylor Scott and White system, Dr. Shiller has also served on the Baylor Medical Board.
As the emerging field of molecular pathology is rapidly evolving, Dr. Shiller has provided many educational forums to empower providers and break down barriers to implementation. She has embraced the opportunity to educate individuals at a larger scale through participation in presentations, video recordings, webinars, and content development. Consequently, Dr. Shiller has also served on steering committees and advisory boards for multiple entities.
An active member of the Association for Molecular Pathology (AMP), Dr. Shiller has also worked to foster a consistent dialogue between molecular pathology and oncology, assisting with developing the ASCO-sponsored Molecular Tumor Board. Quality, accuracy, relevance, timeliness, teamwork, and conscientious stewardship of the patient specimen—all with a patient-centered care focus—are considerations that Dr. Shiller is inspired to bring to reality with the ongoing integration of molecular diagnostics in the field of oncology. She is excited to serve on the Association of Community Cancer Centers Board of Trustees to further impact patient care positively with this focus.
Lawrence D. Wagman, MD, is currently the regional medical director and surgical oncologist for the City of Hope Inland Empire Program. This follows a 10-year hiatus from City of Hope when he served as executive medical director for the Center for Cancer Prevention and Treatment at St. Joseph Hospital in Orange, California (2008-2018). During that time, Dr. Wagman opened an independent surgical oncology practice that focused primarily on hepatopancreaticobiliary (70 percent), gastric, sarcoma, melanoma, and breast cancers.
Previously, during his initial 20-year experience at City of Hope, Dr. Wagman served as the chair of surgery, director of the surgical oncology training program, institutional and national cooperative group principal investigator for many clinical trials, and led a basic science laboratory investigating targetable receptors and liver regeneration.
Dr. Wagman has authored numerous peer-reviewed surgical oncology publications, guest edited Surgical Oncology Clinics of North America twice, and edited Cancer Management: A Multidisciplinary Approach.
Wendi Waugh, BS, RT(R)(T), CMD, CTR, is Administrative Director of Cancer Services & Community Health and Wellness at Southern Ohio Medical Center in Portsmouth, Ohio. She brings more than 30 years of experience in healthcare to this role. She began her career in medical imaging but has spent the last 28 years in oncology. Her passion for community health and community development led her to assume a larger leadership role at Southern Ohio Medical Center in 2013, when she assumed leadership of the Community Health and Wellness teams.
A 13-year survivor of breast cancer, Wendi special interests include community development, public speaking, leadership, dance, fitness, hiking, and biking, and spending time with her family.
She is a graduate of the Radiologic Technology Program at Shawnee State University and received her training for radiation therapy at Weber State University. She completed her Bachelor of Science degree in Health Administration and Health Informatics from Kennedy Western Reserve. Wendi is also a Certified Cancer Registrar and Certified Medical Dosimetrist.